A photo of Vincent Mukkada.

Medical Director, Lumen Inpatient Unit

Medical Director, A4S

Associate Professor, UC Department of Pediatrics

513-636-4415

Board Certified

My Biography & Research

Biography

I specialize in patient care and research related to pediatric gastroenterology — specifically, eosinophilic gastrointestinal (GI) disease and pediatric feeding disorders. The research I pursue is primarily influenced by the health issues that I see every day in the patients who have eosinophilic GI disease and pediatric feeding disorders. I have also become the medical director of our inpatient gastroenterology floor, where we work to continuously improve the quality of care we provide to our patients.

My colleagues and I are working to improve clinical care and monitoring of pediatric patients with eosinophilic disease. We want to better understand the causes and risk factors associated with developing complications in eosinophilic esophagitis. In addition, we are looking to improve the characterization and treatment of feeding problems found in patients with food allergic conditions.

A pediatric feeding disorder is impaired oral intake that is not age-appropriate and can be associated with medical, nutritional, feeding skill and/or psychosocial dysfunction. Continued research into the pathogenesis and best treatment approaches is essential to help children with these disorders.

I was inspired to become a healthcare provider due to my family’s involvement in the healthcare field. My mother is a physician and my father is an academic scientist with a Ph.D. in microbiology. Healthcare and biology surrounded me as I was growing up. While I first resisted following this path, I soon realized that this was the right fit for my career. I was influenced by several inspiring mentors who first encouraged me to enter pediatric gastroenterology and then drew me to study eosinophilic diseases.

In 2010, I was awarded a national Junior Faculty research award from the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. In addition, I achieved the highest patient satisfaction score for the first quarter of 2019 from the Department of Pediatrics at Cincinnati Children’s Hospital Medical Center. My research has been published in numerous manuscripts in journals, including the Journal of Allergy and Clinical Immunology, Journal of Clinical Investigation, Gastroenterology and Genes and Immunity.

Academic Affiliation

Associate Professor, UC Department of Pediatrics

Clinical Divisions

Gastroenterology GI, Feeding and Swallowing Problems, Eosinophilic Disorders, Aerodigestive and Sleep, Aerodigestive and Esophageal

Research Divisions

Eosinophilic Disorders

My Locations

My Education

BA: University of Pennsylvania, Philadelphia, PA, 1998.

MD: University of Cincinnati, Cincinnati, OH, 2002.

Residency: Pediatrics, Brown University / Hasbro Children’s Hospital, Providence, RI, 2002-2005.

Fellowship: Pediatric Gastroenterology, University of Colorado / Children’s Hospital of Colorado, Denver, CO, 2005-2008.

Research Scholar: University of Colorado / Children’s Hospital of Colorado, Denver, CO, 2008-2009.

Certifications: General Pediatrics, 2005; Pediatric Gastroenterology, 2009.

My Publications

Reply. Hirano, I; Collins, MH; Katzka, DA; Mukkada, VA; Falk, GW; Morey, R; Mukasa, L; Desai, NK; Williams, J; Dellon, ES. Clinical Gastroenterology and Hepatology. 2021.

Long-Term Treatment of Eosinophilic Esophagitis with Budesonide Oral Suspension. Dellon, ES; Collins, MH; Katzka, DA; Mukkada, VA; Falk, GW; Morey, R; Goodwin, B; Eisner, JD; Lan, L; Desai, NK; et al. Clinical Gastroenterology and Hepatology. 2021.

Long-Lasting Dissociation of Esophageal Eosinophilia and Symptoms Following Dilation in Adults with Eosinophilic Esophagitis. Safroneeva, E; Pan, Z; King, E; Martin, LJ; Collins, MH; Yang, G; Capocelli, KE; Arva, NC; Abonia, JP; Atkins, D; et al. Clinical Gastroenterology and Hepatology. 2021.

Development of a Core Outcome Set for Therapeutic Studies in Eosinophilic Esophagitis (COREOS): An International Multidisciplinary Consensus. Ma, C; Schoepfer, AM; Safroneeva, E; COREOS Collaborators, . Gastroenterology. 2021.

Budesonide Oral Suspension Improves Outcomes in Patients With Eosinophilic Esophagitis: Results from a Phase 3 Trial. Hirano, I; Collins, MH; Katzka, DA; Mukkada, VA; Falk, GW; Morey, R; Desai, NK; Lan, L; Williams, J; Dellon, ES; et al. Clinical Gastroenterology and Hepatology. 2021.

Replication and meta-analyses nominate numerous eosinophilic esophagitis risk genes. Kottyan, LC; Trimarchi, MP; Lu, X; Caldwell, JM; Maddox, A; Parameswaran, S; Lape, M; D'Mello, RJ; Bonfield, M; Ballaban, A; et al. Journal of Allergy and Clinical Immunology. 2021; 147:255-266.

Very early onset eosinophilic esophagitis is common, responds to standard therapy, and demonstrates enrichment for CAPN14 genetic variants. Lyles, JL; Martin, LJ; Shoda, T; Collins, MH; Trimarchi, MP; He, H; Kottyan, LC; Mukkada, VA; Rothenberg, ME. Journal of Allergy and Clinical Immunology. 2021; 147:244-254.e6.

Prevalence and Predictors of Compromised Bone Mineral Density in Pediatric Eosinophilic Esophagitis. Henderson, AF; Khan, SM; Hornung, LN; Mukkada, VA; Kalkwarf, HJ. Journal of Pediatric Gastroenterology and Nutrition. 2020; 71:764-770.

High Patient Disease Burden in a Cross-sectional, Multicenter Contact Registry Study of Eosinophilic Gastrointestinal Diseases. Jensen, ET; Aceves, SS; Bonis, PA; Bray, K; Book, W; Chehade, M; Collins, MH; Dellon, ES; Falk, GW; Gonsalves, N; et al. Journal of Pediatric Gastroenterology and Nutrition. 2020; 71:524-529.

Eosinophilic Esophagitis: Existing and Upcoming Therapies in an Age of Emerging Molecular and Personalized Medicine. Slack, IF; Schwartz, JT; Mukkada, VA; Hottinger, S; Abonia, JP. Current Allergy and Asthma Reports. 2020; 20.